These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


343 related items for PubMed ID: 3019250

  • 1. [Pathological variability and cancer treatment in lung cancer].
    Kodama T.
    Gan To Kagaku Ryoho; 1986 Sep; 13(9):2708-17. PubMed ID: 3019250
    [Abstract] [Full Text] [Related]

  • 2. [Correlation between tumor histology and prognostic factors in lung cancer cases].
    Kodama T.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):45-53. PubMed ID: 2981517
    [Abstract] [Full Text] [Related]

  • 3. [Histology and prognosis in lung cancer treatment].
    Kodama T, Nishiyama H, Nishiwaki Y.
    Nihon Kyobu Shikkan Gakkai Zasshi; 1990 Feb; 28(2):216-24. PubMed ID: 2162441
    [Abstract] [Full Text] [Related]

  • 4. Prognostic value of histology in resected lung cancer with emphasis on the relevance of the adenocarcinoma subtyping.
    Riquet M, Foucault C, Berna P, Assouad J, Dujon A, Danel C.
    Ann Thorac Surg; 2006 Jun; 81(6):1988-95. PubMed ID: 16731118
    [Abstract] [Full Text] [Related]

  • 5. [Surgery and adjuvant therapy of non-small cell lung cancer].
    Watanabe Y, Yamada T, Ichihashi T, Hashizume Y, Iwa T.
    Gan To Kagaku Ryoho; 1986 Apr; 13(4 Pt 2):1534-46. PubMed ID: 3524465
    [Abstract] [Full Text] [Related]

  • 6. [Prognostic factors in lung cancer based on Shanghai population].
    Liao ML, Gao YT, Yang ZP.
    Zhonghua Jie He He Hu Xi Za Zhi; 1993 Feb; 16(1):36-8, 63-4. PubMed ID: 8403060
    [Abstract] [Full Text] [Related]

  • 7. [Clinical evaluation of the small-cell and poorly differentiated forms of squamous-cell and glandular lung cancers].
    Pirogov AI, Polotskiĭ BE, Al-Ansari N, Volkov SM, Popesku KF.
    Vopr Onkol; 1989 Feb; 35(2):154-8. PubMed ID: 2467441
    [Abstract] [Full Text] [Related]

  • 8. [The relationship of histological type and tumor location to prognosis in 1000 patients with lung resection with special reference to adenocarcinoma].
    Wilde J, Haenselt V, Luft D, Luft P, Welker L.
    Pneumologie; 1990 Dec; 44(12):1287-93. PubMed ID: 2178263
    [Abstract] [Full Text] [Related]

  • 9. [Clinicopathologic features of lung pleomorphic (spindle/giant cell) carcinoma--a report of 17 cases].
    Zhao ZL, Song N, Huang QY, Liu YP, Zhao HR.
    Ai Zheng; 2007 Feb; 26(2):183-8. PubMed ID: 17298750
    [Abstract] [Full Text] [Related]

  • 10. [Clinical value of postoperative chemotherapy for non-small cell lung cancer--with special reference to long-term combined chemotherapy combined with immunotherapy].
    Watanabe Y, Sato H, Iida S, Yamada T, Kobayashi H, Kimoto H, Tsunamura Y, Ichihashi T, Shimizu J, Hashizume Y.
    Gan To Kagaku Ryoho; 1985 Jan; 12(1):21-35. PubMed ID: 2981515
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Surgical-pathologic factors affect long-term outcomes in stage IB (pT2 N0 M0) non-small cell lung cancer: a heterogeneous disease.
    Hsu CP, Hsia JY, Chang GC, Chuang CY, Shai SE, Yang SS, Lee MC, Kwan PC.
    J Thorac Cardiovasc Surg; 2009 Aug; 138(2):426-33. PubMed ID: 19619791
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. [Factors affecting the prognosis in patients with primary lung cancer and brain metastases].
    Yurdakul AS, Halilçolar H, Oztürk C, Tatar D, Karakaya J.
    Tuberk Toraks; 2006 Aug; 54(3):235-42. PubMed ID: 17001540
    [Abstract] [Full Text] [Related]

  • 15. Combined modality therapy of lung cancer.
    Livingston RB.
    Clin Cancer Res; 1997 Dec; 3(12 Pt 2):2638-47. PubMed ID: 10068267
    [Abstract] [Full Text] [Related]

  • 16. [Treatments and diagnosis of lung cancer--field study results: report from japan lung cancer TNM classification committee].
    Yoshimura K.
    Gan To Kagaku Ryoho; 1983 Mar; 10(3):708-14. PubMed ID: 6881994
    [Abstract] [Full Text] [Related]

  • 17. Surgical treatment of primary lung cancer with synchronous brain metastases.
    Billing PS, Miller DL, Allen MS, Deschamps C, Trastek VF, Pairolero PC.
    J Thorac Cardiovasc Surg; 2001 Sep; 122(3):548-53. PubMed ID: 11547308
    [Abstract] [Full Text] [Related]

  • 18. [Combined treatment of lung cancer].
    Trakhtenberg AKh, Kiseleva ES, Kharchenko VP, Zakharchenkov AV, Barchuk AS.
    Vopr Onkol; 1987 Sep; 33(10):25-30. PubMed ID: 3686904
    [Abstract] [Full Text] [Related]

  • 19. Adverse effect of intrapleural Corynebacterium parvum as adjuvant therapy in resected stage I and II non-small cell carcinoma of the lung. Ludwig Lung Cancer Study Group.
    J Thorac Cardiovasc Surg; 1985 Jun; 89(6):842-7. PubMed ID: 2860271
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 18.